Holen Sie sich die Stockscreener-App
0.3764
0.45%
0.0017
Vorhandelsmarkt:
.38
0.0036
+0.96%
Schlusskurs vom Vortag:
$0.3747
Offen:
$0.3792
24-Stunden-Volumen:
384.99K
Relative Volume:
0.20
Marktkapitalisierung:
$12.53M
Einnahmen:
$476.00K
Nettoeinkommen (Verlust:
$-38.52M
KGV:
-0.4163
EPS:
-0.9041
Netto-Cashflow:
$-39.89M
1W Leistung:
+0.11%
1M Leistung:
+14.90%
6M Leistung:
-61.98%
1J Leistung:
-86.21%
1-Tages-Spanne:
$0.3702
$0.3846
1-Wochen-Bereich:
$0.35
$0.395
52-Wochen-Spanne:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3764 | 12.47M | 476.00K | -38.52M | -39.89M | -0.9041 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Can VYNE Therapeutics Inc. stock resist sector downturnsTrade Exit Summary & Low Risk Profit Maximizing Plans - Newser
VYNE Therapeutics (NASDAQ:VYNE) Shares Down 1.6% – What’s Next? - Defense World
Is VYNE Therapeutics Inc (VYNE) positioned for future growth? - Setenews
Can VYNE Therapeutics Inc. stock sustain market leadershipWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - newser.com
Will VYNE Therapeutics Inc. stock continue dividend increasesVolume Spike & Fast Moving Stock Watchlists - newser.com
Why analysts remain bullish on VYNE Therapeutics Inc. stockWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Is VYNE Therapeutics Inc. stock near bottom after declinePortfolio Gains Report & Consistent Profit Trade Alerts - newser.com
Will VYNE Therapeutics Inc. stock benefit from sector rotationTake Profit & Risk Adjusted Swing Trade Ideas - newser.com
Can VYNE Therapeutics Inc. stock withstand economic slowdownEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How VYNE Therapeutics Inc. stock performs during Fed tightening cyclesJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Understanding VYNE Therapeutics Inc.’s price movementProfit Target & Free Growth Oriented Trading Recommendations - newser.com
Will VYNE Therapeutics Inc. stock maintain momentum in 2025Portfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com
What high frequency data says about VYNE Therapeutics Inc.Trade Exit Report & Growth Focused Entry Reports - newser.com
Signal strength of VYNE Therapeutics Inc. stock in tech scannersMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Is VYNE Therapeutics Inc. showing signs of accumulationJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
What Wall Street predicts for VYNE Therapeutics Inc. stock price2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Tools to monitor VYNE Therapeutics Inc. recovery probabilityMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Can swing trading help recover from VYNE Therapeutics Inc. lossesEarnings Risk Summary & High Accuracy Buy Signal Tips - newser.com
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):